Real-world experience with 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN) in the United Kingdom

AIMS: To compare safety outcomes and visual function data acquired in the real-world setting with FAME study results in eyes treated with 0.2 μg/day fluocinolone acetonide (FAc). METHODS: Fourteen UK clinical sites contributed to pseudoanonymised data collected using the same electronic medical reco...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Eye (Lond)
Egile Nagusiak: Bailey, C, Chakravarthy, U, Lotery, A, Menon, G, Talks, J
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2017
Gaiak:
Clinical Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5733285/
https://ncbi.nlm.nih.gov/pubmed/28737758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2017.125
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak